Sequencing a genome is only the beginning. Several layers of analysis are necessary to convert raw sequence data into understanding of functional biology. First, error sources in the original raw data from multiple platforms and diverse applications must be accounted for. Then, as computational methods for assembly, alignment, and variation detection continue to advance, a broad range of genetic analysis applications including: comparative genomics, high-throughput polymorphism detection, analysis of coding and non-coding RNAs, and identifying mutant genes in disease pathways can be addressed. CHI's Next-Generation Sequencing Data Analysis conference combines unique perspectives from a variety of researchers, engineers, biostatisticians, and software developers involved in NGS data analysis.
We invite presentations on transforming sequencing data into serious knowledge.
Topics to Include:
- Data generation
- Data assembly
- Data alignment
- Data annotation
- Data analysis
- Data interpretation
- Data management
- Data storage (protection & integrity)
- Data transfer (cloud computing)
- Data quality control
- Data cost control
Researchers working with technical developments driving this field or researchers applying discovery research are encouraged to submit a title and brief summary of their research for consideration of presentation. Please note that due to limited speaking slots, preference is given to abstracts from those within pharmaceutical and biotech companies, regulators and those from academic centers. Additionally, as per CHI policy, a select number of vendors/consultants who provide products and services to these biopharmaceutical researchers are offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.
Researchers who wish to present their knowledge and expertise to their colleagues are asked to submit an abstract.
All proposals are subject to review by the Scientific Advisory Committee to ensure the highest quality of the conference program.
If you are interested in presenting, please click here to submit a speaking proposal for review.
Deadline for priority consideration: February 15, 2012
For more details on the conference, please contact:
Mary Ann Brown
Executive Conference Director
Cambridge Healthtech Institute
T: (+1) 781-972-5497
E: mabrown@healthtech.com
For partnering and sponsorship information, please contact:
Angela Parsons
Vice President, Business Development
Cambridge Healthtech Institute
T: (+1) 781-972-5467
E: aparsons@healthtech.com